|
Volumn 39, Issue 4, 2004, Pages 301-304
|
Pharmacokinetics of bromotetrandrin (W198) in rats and beagle dogs
|
Author keywords
Absorption; Pharmacokinetics; Protein binding; W198
|
Indexed keywords
BROMOTETRANDRIN;
TETRANDRINE;
UNCLASSIFIED DRUG;
W 198;
ALKALOID;
ANTINEOPLASTIC AGENT;
BENZYLISOQUINOLINE DERIVATIVE;
HERBACEOUS AGENT;
PLASMA PROTEIN;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
AREA UNDER THE CURVE;
ARTICLE;
BIOAVAILABILITY;
CONTROLLED STUDY;
DOG;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
NONHUMAN;
RAT;
SINGLE DRUG DOSE;
ULTRAVIOLET SPECTROSCOPY;
ANIMAL;
COMPARATIVE STUDY;
FEMALE;
HUMAN;
MALE;
METABOLISM;
PROTEIN BINDING;
SPECIES DIFFERENCE;
WISTAR RAT;
ALKALOIDS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
AREA UNDER CURVE;
BENZYLISOQUINOLINES;
BIOLOGICAL AVAILABILITY;
BLOOD PROTEINS;
DOGS;
DRUGS, CHINESE HERBAL;
FEMALE;
HUMANS;
MALE;
PROTEIN BINDING;
RATS;
RATS, WISTAR;
SPECIES SPECIFICITY;
|
EID: 4444298165
PISSN: 05134870
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (5)
|